[Impact of fluoroquinolone use on multidrug-resistant bacteria emergence]

S Nseir1, F Ader, C-H Marquette

  • 1Service de Réanimation Médicale, Hôpital A. Calmette, CHRU de Lille, boulevard du Pr-Leclercq, 59037 Lille cedex, France. s-nseir@chru-lille.fr

Pathologie-Biologie
|September 24, 2005
PubMed

Insights

Increased fluoroquinolone use correlates with rising antibiotic resistance, particularly in Gram-negative bacteria. Strategies like limiting use and duration can combat this growing public health threat.

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Context:

  • Fluoroquinolone antibiotic usage has substantially risen in Europe and the USA over the past 20 years.
  • This increase is partly attributed to the introduction of newer fluoroquinolones with enhanced antipneumococcal activity.
  • Rising fluoroquinolone consumption is linked to escalating rates of bacterial resistance to these drugs.

Purpose:

  • To analyze the association between increased fluoroquinolone use and the development of antimicrobial resistance.
  • To identify specific bacterial pathogens and resistance mechanisms linked to fluoroquinolone exposure.
  • To explore strategies for mitigating fluoroquinolone resistance and the emergence of multidrug-resistant bacteria.

Summary:

  • Fluoroquinolone resistance is increasing in Gram-negative bacilli in industrialized nations.
  • Fluoroquinolone use is a risk factor for infections with resistant pathogens like MRSA, Pseudomonas aeruginosa, Acinetobacter baumannii, ESBL-producing Gram-negatives, and multidrug-resistant bacteria.
  • Nosocomial infections caused by multidrug-resistant bacteria are associated with increased mortality and morbidity, potentially due to inappropriate initial antibiotic therapy.

Impact:

  • Findings highlight the critical need for antimicrobial stewardship programs focused on fluoroquinolones.
  • Recommendations include judicious fluoroquinolone prescribing, limiting treatment duration, and optimizing dosage to preserve antibiotic efficacy.
  • Implementing these strategies can help reduce the incidence of fluoroquinolone resistance and the spread of multidrug-resistant organisms, thereby improving patient outcomes and reducing healthcare costs.

Related Concept Videos

Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...